Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Faes FarmaXMAD:FAE -1.03%93 PB Ratio is 1.82 as of Jul. 21, 2026, which is 16% below its 10-year median of 2.16. GuruFocus rates XMAD:FAE with a GF Score™ of 93/100 and a GF Value™ of €5.18 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 921 Drug Manufacturers companies, Faes Farma ranks better than 51.14% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-21), Faes Farma's share price is €4.345. Faes Farma's Book Value per Share for the quarter that ended in Dec. 2025 was €2.39. Hence, Faes Farma's PB Ratio of today is 1.82.
The historical rank and industry rank for Faes Farma's PB Ratio or its related term are showing as below:
XMAD:FAE'
s PB Ratio Range Over the Past 10 Years
Min: 1.38 Med: 2.16 Max: 3.99
Current: 1.81
During the past 13 years, Faes Farma's highest PB Ratio was 3.99. The lowest was 1.38. And the median was 2.16.
XMAD:FAE's PB Ratio is ranked better than 51.14% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.86
vs XMAD:FAE: 1.81
During the past 12 months, Faes Farma's average Book Value Per Share Growth Rate was 2.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Faes Farma was 10.70% per year. The lowest was -8.30% per year. And the median was 7.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Faes Farma PB Ratio Related Terms
Faes Farma PB Ratio Historical Data
* Premium members only.
The historical data trend for Faes Farma's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's PB Ratio distribution charts can be found below:
* The bar in red indicates where Faes Farma's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Faes Farma's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Faes Farma (XMAD:FAE) has a PB Ratio of 1.82 as of Jul. 21, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Faes Farma and its competitors. This is 16% below median its historical median of 2.16. Over the past decade, Faes Farma's PB Ratio has ranged from 1.38 to 3.99. According to the industry distribution chart, Faes Farma ranks #450 out of 921 companies in the Drug Manufacturers industry, placing it in the top 48.9%.
Is Faes Farma's PB Ratio too high?
Faes Farma's current PB Ratio of 1.82 is 16% below median its 10-year median of 2.16. Over the past 10 years, this metric has ranged from a low of 1.38 to a high of 3.99. The Drug Manufacturers industry median PB Ratio is 1.86. Faes Farma's value of 1.82 is 2.2% below this industry median. Based on the distribution chart, Faes Farma ranks #450 out of 921 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Faes Farma has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Faes Farma ranks #450 out of 921 companies for PB Ratio. This puts Faes Farma in the upper half of its industry. The industry median PB Ratio is 1.86. Faes Farma's value of 1.82 is 2.2% below this benchmark. Historically, Faes Farma's own PB Ratio has ranged from 1.38 to 3.99 over the past decade. While the company's 10-year median is 2.16 vs. the industry median of 1.86, Faes Farma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.86, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Faes Farma's current PB Ratio of 1.82 is 2.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Faes Farma and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Faes Farma's current PB Ratio is 1.82, which is 16% below median its own 10-year median of 2.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Based on GuruFocus' analysis, Faes Farma (XMAD:FAE) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.18, compared to a current price of €4.35 — trading 16.1% below its estimated fair value. The current PB Ratio is 1.82, which is 16% below median its 10-year median of 2.16 and 2.2% below the Drug Manufacturers industry median of 1.86. Faes Farma's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Faes Farma (XMAD:FAE), the current PB Ratio is 1.82 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Faes Farma (XMAD:FAE) Overvalued in 2026?
Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued.
The current stock price of €4.35 is trading 16.1% below its estimated GF Value™ of €5.18.
GuruFocus considers Faes Farma to be Modestly Undervalued.
Key valuation signals for XMAD:FAE:
PB Ratio: 1.82 (16% below median its 10-year median of 2.16)
GF Value™: €5.18 vs. price of €4.35 (16.1% below fair value)
Industry Position: 2.2% below the Drug Manufacturers median (#450 of 921)
No single metric tells the full story. See the XMAD:FAE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
93GF Score
Get the complete analysis for XMAD:FAE
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:FAE has been successfully added to your 
